1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Wan, Z.L. Hua, Q.X. Huang, K. Hu, S.Q. Philips, N.B. Katsoyannis, J.W. Weiss, M.A. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C3 H7 N O2 89.093 D-ALANINE D-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking To be Published 0353 Chiral Protein Engineering and its Application in G Health 2383.698 Insulin A chain UNP rsidues 90-110 P28K, K29P 1 man polymer 3462.005 Insulin B chain UNP rsidues 25-54 1 man polymer Insulin A chain Insulin B chain no no GIVEQCCTSICSLYQLENYCN GIVEQCCTSICSLYQLENYCN A polypeptide(L) no yes FVNQHLCGSHLVEALYLVC(DAL)ER(DAL)FFYTKPT FVNQHLCGSHLVEALYLVCAERAFFYTKPT B polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human sample INS 9606 Homo sapiens 562 Escherichia coli pBR322 human sample INS 9606 Homo sapiens 562 Escherichia coli pBR322 repository Initial release 1 0 2011-08-31 Residues 20 and 23 in chain B are engineered to be D-ALA. BMRB Y RCSB 2010-08-09 REL REL THIS STRUCTURE WAS DETERMINED USING STANDARD 2D HOMONUCLEAR NMR TECHNIQUES. STRUCTURES WITH THE LOWEST ENERG 40 20 2D TOCSY NOESY COSY 0.5 mM 7.0 mbar 298 K DISTANCE GEOMETRY AND SIMULATED 1 closest to the average 0.5 mM entity_1-1, 90% H2O/10% D2O 90% H2O/10% D2O Brunger structure solution X-PLOR 3.5 Brunger refinement X-PLOR 3.5 700 Bruker DRX BRUKER DRX GLY 1 n 1 GLY 1 A ILE 2 n 2 ILE 2 A VAL 3 n 3 VAL 3 A GLU 4 n 4 GLU 4 A GLN 5 n 5 GLN 5 A CYS 6 n 6 CYS 6 A CYS 7 n 7 CYS 7 A THR 8 n 8 THR 8 A SER 9 n 9 SER 9 A ILE 10 n 10 ILE 10 A CYS 11 n 11 CYS 11 A SER 12 n 12 SER 12 A LEU 13 n 13 LEU 13 A TYR 14 n 14 TYR 14 A GLN 15 n 15 GLN 15 A LEU 16 n 16 LEU 16 A GLU 17 n 17 GLU 17 A ASN 18 n 18 ASN 18 A TYR 19 n 19 TYR 19 A CYS 20 n 20 CYS 20 A ASN 21 n 21 ASN 21 A PHE 1 n 1 PHE 1 B VAL 2 n 2 VAL 2 B ASN 3 n 3 ASN 3 B GLN 4 n 4 GLN 4 B HIS 5 n 5 HIS 5 B LEU 6 n 6 LEU 6 B CYS 7 n 7 CYS 7 B GLY 8 n 8 GLY 8 B SER 9 n 9 SER 9 B HIS 10 n 10 HIS 10 B LEU 11 n 11 LEU 11 B VAL 12 n 12 VAL 12 B GLU 13 n 13 GLU 13 B ALA 14 n 14 ALA 14 B LEU 15 n 15 LEU 15 B TYR 16 n 16 TYR 16 B LEU 17 n 17 LEU 17 B VAL 18 n 18 VAL 18 B CYS 19 n 19 CYS 19 B DAL 20 n 20 DAL 20 B GLU 21 n 21 GLU 21 B ARG 22 n 22 ARG 22 B DAL 23 n 23 DAL 23 B PHE 24 n 24 PHE 24 B PHE 25 n 25 PHE 25 B TYR 26 n 26 TYR 26 B THR 27 n 27 THR 27 B LYS 28 n 28 LYS 28 B PRO 29 n 29 PRO 29 B THR 30 n 30 THR 30 B author_defined_assembly 2 dimeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 1 B B O H VAL TYR 12 16 1.45 1 A A O H ILE CYS 2 6 1.56 1 B B O H SER GLU 9 13 1.57 2 B B O H VAL TYR 12 16 1.41 2 A A O H LEU TYR 16 19 1.47 2 A B HD21 O ASN DAL 21 23 1.47 2 B B O H SER GLU 9 13 1.53 3 B B O H VAL TYR 12 16 1.45 3 A B O H CYS LEU 6 6 1.48 3 A A O H ILE GLN 2 5 1.50 3 B B O H SER GLU 9 13 1.51 4 B B O H VAL TYR 12 16 1.51 4 A A O H ILE GLN 2 5 1.53 4 B B O H SER GLU 9 13 1.56 5 B B O H VAL TYR 12 16 1.44 5 A A O H ILE GLN 2 5 1.46 5 B B O H SER GLU 9 13 1.57 6 A B O H CYS LEU 6 6 1.47 6 B B O H VAL TYR 12 16 1.50 6 A A O H ILE GLN 2 5 1.52 6 B B O H SER GLU 9 13 1.60 7 B B O H VAL TYR 12 16 1.41 7 A B O H CYS LEU 6 6 1.46 7 A A O H ILE GLN 2 5 1.49 7 B B O H SER GLU 9 13 1.56 8 B B O H VAL TYR 12 16 1.42 8 A A O H GLN ASN 15 18 1.58 9 B B O H VAL TYR 12 16 1.45 9 A A O H ILE GLN 2 5 1.46 9 B B O H SER GLU 9 13 1.53 9 A B O H CYS LEU 6 6 1.53 10 B B O H VAL TYR 12 16 1.43 10 A A O H ILE GLN 2 5 1.50 10 B B O H SER GLU 9 13 1.56 10 A A O H LEU TYR 16 19 1.59 11 B B O H VAL TYR 12 16 1.41 11 A A O H ILE GLN 2 5 1.45 11 A B O H CYS LEU 6 6 1.49 11 B B O H SER GLU 9 13 1.57 11 A B HD21 O ASN DAL 21 23 1.58 12 B B O H VAL TYR 12 16 1.39 12 B B O H SER GLU 9 13 1.53 13 B B O H VAL TYR 12 16 1.43 13 A A O H LEU TYR 16 19 1.53 13 B B O H SER GLU 9 13 1.54 14 B B O H VAL TYR 12 16 1.44 14 A A O H ILE GLN 2 5 1.46 14 A B O H CYS LEU 6 6 1.48 14 B B O H SER GLU 9 13 1.56 15 B B O H VAL TYR 12 16 1.45 15 A A O H ILE GLN 2 5 1.47 15 B B O H SER GLU 9 13 1.56 16 B B O H VAL TYR 12 16 1.40 17 B B O H VAL TYR 12 16 1.43 17 A A O H ILE GLN 2 5 1.49 17 B B O H SER GLU 9 13 1.56 18 B B O H VAL TYR 12 16 1.40 18 B B O H SER GLU 9 13 1.59 19 B B O H VAL TYR 12 16 1.43 19 A A O H ILE GLN 2 5 1.47 19 B B O H SER GLU 9 13 1.56 20 B B O H VAL TYR 12 16 1.41 20 A A O H GLN ASN 15 18 1.56 20 A A O H ILE GLN 2 5 1.58 20 B B O H SER GLU 9 13 1.58 1 B ARG 22 0.315 SIDE CHAIN 2 B ARG 22 0.096 SIDE CHAIN 3 B ARG 22 0.305 SIDE CHAIN 4 B ARG 22 0.263 SIDE CHAIN 5 B ARG 22 0.212 SIDE CHAIN 6 B ARG 22 0.291 SIDE CHAIN 7 B ARG 22 0.318 SIDE CHAIN 8 B ARG 22 0.179 SIDE CHAIN 9 B ARG 22 0.298 SIDE CHAIN 10 B ARG 22 0.217 SIDE CHAIN 11 B ARG 22 0.280 SIDE CHAIN 12 B ARG 22 0.265 SIDE CHAIN 13 B ARG 22 0.160 SIDE CHAIN 14 B ARG 22 0.297 SIDE CHAIN 15 B ARG 22 0.314 SIDE CHAIN 16 B ARG 22 0.272 SIDE CHAIN 18 B ARG 22 0.235 SIDE CHAIN 19 B ARG 22 0.275 SIDE CHAIN 20 B ARG 22 0.307 SIDE CHAIN 1 A SER 9 -88.27 -155.25 1 A CYS 20 -69.97 -178.79 1 B VAL 2 -143.38 13.44 1 B ASN 3 -176.85 105.64 1 B GLN 4 -160.21 56.26 1 B CYS 19 -84.98 -79.73 1 B GLU 21 -164.45 -41.97 1 B PHE 24 -49.91 -176.85 2 A CYS 7 -107.81 -66.50 2 A SER 9 -117.04 -161.09 2 B ASN 3 44.28 92.77 2 B CYS 19 -105.83 -65.43 2 B GLU 21 -165.62 -35.17 2 B DAL 23 122.74 61.99 2 B PHE 24 -54.98 -170.37 3 A CYS 7 -133.11 -40.61 3 A CYS 20 -53.13 176.72 3 B VAL 2 -160.13 -159.97 3 B DAL 20 89.37 -49.26 3 B ARG 22 -141.50 -75.44 3 B DAL 23 134.79 59.55 3 B PHE 24 -53.69 -171.81 4 B GLN 4 -160.10 103.25 4 B CYS 7 -126.93 -169.41 4 B GLU 21 176.62 72.07 4 B ARG 22 -175.22 -62.69 4 B PHE 24 -51.57 -176.02 5 A CYS 7 -132.18 -63.36 5 A SER 9 -129.85 -160.52 5 B CYS 7 -126.88 -166.96 5 B CYS 19 -93.25 -76.21 5 B GLU 21 176.53 -29.24 5 B DAL 23 121.03 53.47 5 B PHE 24 -49.88 -176.41 5 B LYS 28 165.68 -51.40 6 A CYS 7 -130.04 -50.25 6 A SER 9 -119.03 -161.66 6 B GLU 21 -178.79 70.00 6 B ARG 22 -163.68 -55.03 6 B PHE 24 -54.14 -168.35 7 A CYS 7 -127.05 -56.81 7 B GLN 4 -160.39 104.53 7 B CYS 19 -83.59 -71.14 7 B DAL 20 62.32 97.53 7 B GLU 21 80.43 39.47 7 B ARG 22 -146.33 -48.89 7 B DAL 23 107.94 60.72 7 B PHE 24 -56.44 -177.25 7 B THR 27 -109.22 -155.68 7 B LYS 28 -172.84 130.41 7 B PRO 29 -78.19 -156.73 8 B VAL 2 -141.77 13.35 8 B ASN 3 59.89 115.04 8 B ARG 22 -96.26 -70.42 8 B DAL 23 134.66 50.38 8 B PHE 24 -49.12 178.96 9 A CYS 7 -126.29 -63.53 9 B DAL 20 88.29 -31.37 9 B ARG 22 -146.94 -72.18 9 B DAL 23 130.48 63.17 9 B PHE 24 -59.38 -169.14 10 A CYS 7 -126.53 -52.81 10 A SER 9 -123.62 -152.94 10 B ASN 3 51.66 80.52 10 B CYS 19 -82.14 -71.56 10 B GLU 21 179.05 46.52 10 B ARG 22 -152.07 -48.52 10 B PHE 24 -52.26 -174.33 10 B LYS 28 -152.86 63.54 11 A CYS 7 -135.44 -61.87 11 A SER 9 -111.90 -147.33 11 B CYS 19 -85.70 -72.90 11 B GLU 21 -177.50 -35.24 11 B DAL 23 103.76 63.05 11 B PHE 24 -53.86 -169.41 12 A ILE 2 -105.25 -91.56 12 A CYS 7 -131.89 -64.52 12 A SER 9 -113.34 -155.25 12 B VAL 2 -141.56 12.85 12 B ASN 3 -163.49 117.99 12 B GLN 4 -160.05 49.17 12 B CYS 19 -87.24 -71.68 12 B PHE 24 -52.78 -172.67 12 B THR 27 -103.84 77.85 13 A SER 9 -121.71 -160.91 13 B ASN 3 55.41 88.97 13 B GLN 4 -160.37 71.63 13 B CYS 19 -91.28 -72.37 13 B GLU 21 -164.20 -38.47 13 B PHE 24 -48.84 -179.65 14 A CYS 7 -127.35 -58.18 14 A CYS 20 -68.43 -176.24 14 B CYS 19 -98.08 -75.92 14 B GLU 21 -177.13 77.39 14 B ARG 22 173.50 -63.74 14 B PHE 24 -52.39 -172.55 15 A CYS 7 -133.74 -73.47 15 A SER 9 -115.76 -144.79 15 B ASN 3 54.86 104.20 15 B GLN 4 -160.24 99.76 15 B DAL 20 69.98 96.64 15 B GLU 21 77.38 41.77 15 B ARG 22 -139.05 -58.60 15 B PHE 24 -53.06 -173.13 16 A SER 9 -134.83 -157.34 16 A CYS 20 -61.15 -175.58 16 B CYS 19 -82.78 -72.33 16 B GLU 21 -115.67 50.44 16 B ARG 22 -127.66 -69.05 16 B DAL 23 126.38 56.63 16 B PHE 24 -53.35 -173.88 16 B THR 27 -84.50 -74.55 16 B LYS 28 57.55 71.95 17 A CYS 7 -131.25 -40.30 17 A SER 9 -136.86 -153.20 17 A CYS 20 -54.39 172.07 17 B GLN 4 -160.53 107.59 17 B CYS 19 -82.38 -70.52 17 B DAL 20 88.67 -42.55 17 B ARG 22 -159.84 -53.89 17 B DAL 23 106.29 65.47 17 B PHE 24 -62.81 -167.67 17 B PRO 29 -77.89 -155.76 18 A ILE 2 -101.73 -62.72 18 A CYS 7 -124.04 -74.91 18 A CYS 20 -59.56 -170.13 18 B GLN 4 -160.47 99.69 18 B GLU 21 177.23 71.57 18 B ARG 22 176.65 -41.72 18 B DAL 23 91.35 63.01 18 B PHE 24 -53.04 -173.06 18 B LYS 28 56.58 102.74 18 B PRO 29 -77.44 -90.87 19 A CYS 7 -136.45 -55.60 19 A CYS 20 -58.06 173.28 19 B ARG 22 -179.83 -55.59 19 B DAL 23 107.58 62.00 19 B PHE 24 -55.82 -170.17 19 B LYS 28 71.85 61.97 20 A SER 9 -163.01 -166.80 20 B ASN 3 54.17 101.57 20 B GLN 4 -160.15 98.74 20 B CYS 19 -94.80 -65.50 20 B PHE 24 -50.13 179.48 20 B LYS 28 -163.00 93.10 20 B PRO 29 -77.42 -91.03 Insulin A chain/Insulin B chain closest to the average, model 1 NMR Structure of human insulin mutant GLY-B20-D-ALA, GLY-B23-D-ALA PRO-B28-LYS, LYS-B29-PRO, 20 Structures 1 N N 2 N N A ILE 2 A ILE 2 HELX_P A CYS 7 A CYS 7 1 1 6 A SER 12 A SER 12 HELX_P A GLU 17 A GLU 17 1 2 6 A ASN 18 A ASN 18 HELX_P A CYS 20 A CYS 20 5 3 3 B CYS 7 B CYS 7 HELX_P B CYS 19 B CYS 19 1 4 13 disulf 2.020 A CYS 6 A SG CYS 6 1_555 A CYS 11 A SG CYS 11 1_555 disulf 2.019 A CYS 7 A SG CYS 7 1_555 B CYS 7 B SG CYS 7 1_555 disulf 2.018 A CYS 20 A SG CYS 20 1_555 B CYS 19 B SG CYS 19 1_555 covale 1.305 B CYS 19 B C CYS 19 1_555 B DAL 20 B N DAL 20 1_555 covale 1.302 B DAL 20 B C DAL 20 1_555 B GLU 21 B N GLU 21 1_555 covale 1.303 B ARG 22 B C ARG 22 1_555 B DAL 23 B N DAL 23 1_555 covale 1.306 B DAL 23 B C DAL 23 1_555 B PHE 24 B N PHE 24 1_555 HORMONE HORMONE, HUMAN INSULIN, MUTANT INS_HUMAN UNP 1 90 P01308 GIVEQCCTSICSLYQLENYCN INS_HUMAN UNP 2 25 P01308 FVNQHLCGSHLVEALYLVCGERGFFYTPKT 90 110 2L1Y 1 21 P01308 A 1 1 21 25 54 2L1Y 1 30 P01308 B 2 1 30 2 GLY SEE REMARK 999 DAL 20 2L1Y B P01308 UNP 44 20 2 GLY SEE REMARK 999 DAL 23 2L1Y B P01308 UNP 47 23 2 PRO ENGINEERED MUTATION LYS 28 2L1Y B P01308 UNP 52 28 2 LYS ENGINEERED MUTATION PRO 29 2L1Y B P01308 UNP 53 29 BINDING SITE FOR RESIDUE DAL B 20 Software 4 BINDING SITE FOR RESIDUE DAL B 23 Software 5 B TYR 16 B TYR 16 4 1_555 B LEU 17 B LEU 17 4 1_555 B CYS 19 B CYS 19 4 1_555 B GLU 21 B GLU 21 4 1_555 A ASN 21 A ASN 21 5 1_555 B TYR 16 B TYR 16 5 1_555 B GLU 21 B GLU 21 5 1_555 B ARG 22 B ARG 22 5 1_555 B PHE 24 B PHE 24 5 1_555